SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Business
Born In The Texas Med Center: Houston Is Research Headquarters For New Era Of Life-Saving Medical Devices
April 5, 2010
 · 
1 min read
BioMidwest
Elekta’s Stereotactic Radiation Therapy Effective In Primary Tumor Control, University of Texas Southwestern Medical Center And William Beaumont Hospital Studies Find
April 2, 2010
 · 
4 min read
Policy
Medical Device-Makers Among Those Impacted by New Healthcare Bill
April 2, 2010
 · 
1 min read
Lone Star Bio
Drug That Extends Life Span Prevents Alzheimer’s Deficits, University of Texas Health Science Center Study
April 2, 2010
 · 
1 min read
Lone Star Bio
Fight Cancer By Picking Off Cells Before They Go Rogue; Chemical ‘Nips Cancer In The Bud’, University of Texas MD Anderson Cancer Center Study
April 2, 2010
 · 
1 min read
Lone Star Bio
Companies Riding The Genome Wave
April 1, 2010
 · 
1 min read
Lone Star Bio
Tuberculosis Good and Bad News: Blood Pressure Drug Shows Promise, but TB Bacterium Might Be More Resistant Than Thought, UT Southwestern Medical Center Study
March 31, 2010
 · 
1 min read
Lone Star Bio
UT Southwestern Medical Center Researchers Find Clues to TB Drug Resistance
March 30, 2010
 · 
1 min read
Lone Star Bio
Paired Drugs Kill Precancerous Colon Polyps, Spare Normal Tissue, University of Texas MD Anderson Cancer Center Study
March 29, 2010
 · 
1 min read
Research Store
Biotech Bay
Cardiovascular Market: Slow Growth In Cardiovascular Disease Will Be Offset By Prospects In Diabetes
March 29, 2010
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Load More